XML 43 R28.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Acquisitions and Strategic Transaction Expenses Business Combination (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017 | Dec. 31, 2015
Business Acquisition [Line Items] |  |
Business Acquisition, Pro Forma Information [Table Text Block] |
(In millions) |  | Revenue |  | Earnings
Actual from 2/3/2017 - 12/31/2017(3) |  | $ | 1,062 |  |  | *
2017 supplemental pro forma from 1/1/2017 - 12/31/2017(1)(2) |  | $ | 1,293 |  |  | $ | 180 |
2016 supplemental pro forma from 1/1/2016 - 12/31/2016(1)(2) |  | $ | 1,418 |  |  | $ | 22 |
______________________________ * Impracticable to calculate. (1) 2017 supplemental pro forma earnings were adjusted to exclude $66.3 million of nonrecurring expense related to the fair value adjustment to acquisition-date inventory and $69.5 million of acquisition and integration-related costs. 2016 supplemental pro forma earnings were adjusted to include these charges. |
Excelsior [Member] |  |
Business Acquisition [Line Items] |  |
Schedule of Business Acquisitions, by Acquisition [Table Text Block] |  | The following table summarizes the final purchase price and the allocation of the purchase price related to the assets and liabilities retained (in thousands):
Fair Value of Consideration: |
Cash, net of cash acquired | $ | 56,786 |
Allocation of the Purchase Price: |
Net assets sold to Excelsior Medical, LLC | $ | 28,970 |
Prepaid expenses and other current assets | 254 |
Deferred tax asset/liabilities | 4,426 |
Property, plant and equipment | 3,982 |
Identifiable intangible assets(1) | 18,076 |
Goodwill | 4,985 |
Assumed liabilities | (3,907 | )
Net Assets Acquired | $ | 56,786 |
______________________________ (1) Identifiable intangible assets included $7.1 million of non-contractual customer relationships, $3.7 million of developed technology and $7.3 million of trade name. The weighted-average amortization period for the total identifiable intangible assets is approximately fourteen years. The weighted-average amortization period for customer relationships and trade name is fifteen years and the weighted-average amortization period for the developed technology is ten years.
Hospira [Member] |  |
Business Acquisition [Line Items] |  |
Schedule of Business Acquisitions, by Acquisition [Table Text Block] | The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets and liabilities purchased (in thousands, except per share data):
Cash consideration for acquired assets |  | $ | 180,785 |
Fair value of Seller Note |  | 75,000 |
Fair value of contingent consideration payable to Pfizer (long-term) |  | 19,000 |
Issuance of ICU Medical, Inc. common shares: |  |
Number of shares issued to Pfizer |  | 3,200 |
Price per share (ICU's trading closing share price on the Closing Date) |  | $ | 140.75 |
Market price of ICU shares issued to Pfizer |  | $ | 450,400 |
Less: Discount due to lack of marketability of 8.3% |  | (37,261 | )
Equity portion of purchase price |  | 413,139 |
Total Consideration |  | $ | 687,924 |
Purchase Price Allocation: |  |
Cash and cash equivalents |  | $ | 31,082 |
Trade receivables |  | 362 |
Inventories |  | 417,622 |
Prepaid expenses and other assets |  | 13,911 |
Property, plant and equipment |  | 288,134 |
Intangible assets(1) |  | 131,000 |
Other assets |  | 29,270 |
Accounts payable |  | (12,381 | )
Accrued liabilities |  | (47,936 | )
Long-term liabilities(2) |  | (67,170 | )
Total identifiable net assets acquired |  | $ | 783,894 |
Deferred tax, net |  | (25,080 | )
Estimated Gain on Bargain Purchase |  | (70,890 | )
Estimated Purchase Consideration |  | $ | 687,924 |
______________________________ (1) Identifiable intangible assets includes $48 million of customer relationships, $44 million of developed technology - pumps and dedicated sets, $34 million of developed technology - consumables, and $5 million of in-process research and development ("IPR&D"). The weighted amortization period for the total identifiable assets is approximately nine years, for customer relationships the weighted amortization period is eight years, for the developed technology - pumps and dedicated sets the weighted amortization period is ten years and for the developed technology - consumables the weighted amortization period is twelve years. The IPR&D is non-amortizing until the associated research and development efforts are complete. (2) Long-term liabilities primarily consisted of contract liabilities, product liabilities and long-term employee benefits. |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=icui_ExcelsiorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=icui_HospiraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |